Efficacy and safety of Shenyankangfu Tablet, a Chinese patent medicine, for primary glomerulonephritis: A multicenter randomized controlled trial

Jie Wu, Shu-wei Duan, Hong-tao Yang, Yue-yi Deng, Wei Li, Ya-ni He, Zhao-hui Ni, Yong-li Zhan, Shan Lin, Zhi-yong Guo, Jun Zhu, Jing-ai Fang, Xu-sheng Liu, Li-hua Wang, Rong Wang, Nian-song Wang, Xiao-hong Cheng, Li-qun He, Ping Luo, Shi-ren Sun, Ji-feng Sun, Ai-ping Yin, Geng-ru Jiang, Hong-yu Chen, Wen-hu Liu, Hong-li Lin, Meng Liang, Lu Ma, Ming Chen, Li-qun Song, Jian Chen, Qing Zhu, Chang-ying Xing, Yun Li, Ji-ning Gao, Rong-shan Li, Ying Li, Hao Zhang, Ying Lu, Qiao-ling Zhou, Jun-zhou Fu, Qiang He, Guang-yan Cai, Xiang-mei Chen

Open source

DOI: 10.1016/j.joim.2021.01.009
Published: 2021-03
Container: Journal of Integrative Medicine
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.joim.2021.01.009,
  title = {Efficacy and safety of Shenyankangfu Tablet, a Chinese patent medicine, for primary glomerulonephritis: A multicenter randomized controlled trial},
  author = {Jie Wu and Shu-wei Duan and Hong-tao Yang and Yue-yi Deng and Wei Li and Ya-ni He and Zhao-hui Ni and Yong-li Zhan and Shan Lin and Zhi-yong Guo and Jun Zhu and Jing-ai Fang and Xu-sheng Liu and Li-hua Wang and Rong Wang and Nian-song Wang and Xiao-hong Cheng and Li-qun He and Ping Luo and Shi-ren Sun and Ji-feng Sun and Ai-ping Yin and Geng-ru Jiang and Hong-yu Chen and Wen-hu Liu and Hong-li Lin and Meng Liang and Lu Ma and Ming Chen and Li-qun Song and Jian Chen and Qing Zhu and Chang-ying Xing and Yun Li and Ji-ning Gao and Rong-shan Li and Ying Li and Hao Zhang and Ying Lu and Qiao-ling Zhou and Jun-zhou Fu and Qiang He and Guang-yan Cai and Xiang-mei Chen},
  year = {2021},
  journal = {Journal of Integrative Medicine},
  doi = {10.1016/j.joim.2021.01.009},
  url = {https://doi.org/10.1016/j.joim.2021.01.009}
}

RIS

TY  - JOUR
TI  - Efficacy and safety of Shenyankangfu Tablet, a Chinese patent medicine, for primary glomerulonephritis: A multicenter randomized controlled trial
AU  - Jie Wu
AU  - Shu-wei Duan
AU  - Hong-tao Yang
AU  - Yue-yi Deng
AU  - Wei Li
AU  - Ya-ni He
AU  - Zhao-hui Ni
AU  - Yong-li Zhan
AU  - Shan Lin
AU  - Zhi-yong Guo
AU  - Jun Zhu
AU  - Jing-ai Fang
AU  - Xu-sheng Liu
AU  - Li-hua Wang
AU  - Rong Wang
AU  - Nian-song Wang
AU  - Xiao-hong Cheng
AU  - Li-qun He
AU  - Ping Luo
AU  - Shi-ren Sun
AU  - Ji-feng Sun
AU  - Ai-ping Yin
AU  - Geng-ru Jiang
AU  - Hong-yu Chen
AU  - Wen-hu Liu
AU  - Hong-li Lin
AU  - Meng Liang
AU  - Lu Ma
AU  - Ming Chen
AU  - Li-qun Song
AU  - Jian Chen
AU  - Qing Zhu
AU  - Chang-ying Xing
AU  - Yun Li
AU  - Ji-ning Gao
AU  - Rong-shan Li
AU  - Ying Li
AU  - Hao Zhang
AU  - Ying Lu
AU  - Qiao-ling Zhou
AU  - Jun-zhou Fu
AU  - Qiang He
AU  - Guang-yan Cai
AU  - Xiang-mei Chen
PY  - 2021
JO  - Journal of Integrative Medicine
DO  - 10.1016/j.joim.2021.01.009
UR  - https://doi.org/10.1016/j.joim.2021.01.009
ER  -

APA

Wu, J., Duan, S., Yang, H., Deng, Y., Li, W., He, Y., Ni, Z., Zhan, Y., Lin, S., Guo, Z., Zhu, J., Fang, J., Liu, X., Wang, L., Wang, R., Wang, N., Cheng, X., He, L., Luo, P., Sun, S., Sun, J., Yin, A., Jiang, G., Chen, H., Liu, W., Lin, H., Liang, M., Ma, L., Chen, M., Song, L., Chen, J., Zhu, Q., Xing, C., Li, Y., Gao, J., Li, R., Li, Y., Zhang, H., Lu, Y., Zhou, Q., Fu, J., He, Q., Cai, G., & Chen, X. (2021). Efficacy and safety of Shenyankangfu Tablet, a Chinese patent medicine, for primary glomerulonephritis: A multicenter randomized controlled trial. Journal of Integrative Medicine. https://doi.org/10.1016/j.joim.2021.01.009

Source records

crossref · retrieved 2026-09-25T03:33:40.429Z